Neuroscience Quarterly

Neuroscience Quarterly. It is a peer-reviewed scientific journal that publishes original research and review articles across the broad spectrum of modern neuroscience. Established in 2019, the journal is published by Elsevier and operates under a hybrid open-access model, releasing four issues per year. Its editorial mission is to disseminate high-impact findings that bridge molecular, cellular, systems, and cognitive approaches to understanding the nervous system.

History and publication details

The journal was launched in 2019 by Elsevier, a major publisher in the STM publishing sector, to address the rapidly expanding interdisciplinary nature of neuroscience research. Its inaugural editorial board was chaired by prominent figures from institutions like the Massachusetts Institute of Technology and the Max Planck Society. Published quarterly from editorial offices in Amsterdam, the journal adopted a continuous publication model online while maintaining traditional print volumes for archival purposes. The founding coincided with major initiatives in the field, such as the BRAIN Initiative and the Human Brain Project, reflecting a demand for consolidated, high-quality publication venues.

Scope and editorial focus

The journal's scope encompasses all major sub-disciplines within neuroscience, with a particular emphasis on translational research and integrative studies. Key areas of focus include neurogenetics, synaptic plasticity, functional neuroimaging, computational neuroscience, and the neural basis of behavior and neurological disorders. It encourages submissions that employ innovative methodologies, from optogenetics and CLARITY to advanced MRI techniques and machine learning applications in neuroinformatics. The editorial focus is on work that provides mechanistic insights or has clear implications for understanding conditions like Alzheimer's disease, Parkinson's disease, epilepsy, and major depressive disorder.

Abstracting, indexing, and impact

*Neuroscience Quarterly* is abstracted and indexed in several major scientific databases, including Scopus, the Science Citation Index Expanded, PubMed, and the Directory of Open Access Journals. According to the Journal Citation Reports, it received its first Impact Factor of 2.8 in 2023. The journal is also indexed in EMBASE, Chemical Abstracts Service, and PsycINFO, ensuring broad visibility across the biomedical sciences. Its articles are regularly cited in high-profile journals such as Nature Neuroscience, Neuron, and the Journal of Neuroscience.

Notable articles and special issues

The journal has published several highly cited articles, including a 2021 review on microglia in neurodevelopment and a 2022 original research paper on deep brain stimulation for treatment-resistant depression. It regularly commissions special issues on emerging topics; notable collections have focused on the gut-brain axis, advances in cryo-electron microscopy for structural biology of neural proteins, and the ethical implications of neural engineering technologies. These special issues often feature contributions from leading researchers at institutions like Stanford University, the Karolinska Institutet, and the Howard Hughes Medical Institute.

Editorial board and governance

The journal is overseen by an international editorial board comprising experts from leading academic and research centers worldwide. The current editor-in-chief is a professor of neurobiology affiliated with University College London, supported by senior editors from the National Institutes of Health, the Riken institute, and the University of California, San Francisco. The board manages a rigorous peer-review process, utilizing a database of reviewers from the global neuroscience community to ensure scholarly rigor and integrity in line with guidelines from the Committee on Publication Ethics.

Category:Neuroscience journals Category:Elsevier academic journals Category:Publications established in 2019